Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Adavosertib
Nonpapillary Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Adavosertib
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Adavosertib
Glioma
National Cancer Institute (NCI)P2CCC (50)
Dasatinib
Melanoma
National Cancer Institute (NCI)P2CCC (50)
Diphenoxylate
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Diphenoxylate
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Diphenoxylate
Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Fluoromisonidazole
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Ipatasertib
Ovarian Cancer
National Cancer Institute (NCI)P2CCC (50)
Kras Tcr-Transduced Pbl
Colorectal Cancer
National Cancer Institute (NCI)P2CCC (50)
Mirdametinib
B-Cell Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)P2CCC (50)
Mirdametinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
National Cancer Institute (NCI)P2CCC (50)
mk-2206
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Olaparib
Acute Myeloid Leukemia
National Cancer Institute (NCI)P2CCC (50)
Relatlimab
Plasma Cell Myeloma
National Cancer Institute (NCI)P2CCC (50)
Taselisib
Colorectal Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Taselisib
Glioma
National Cancer Institute (NCI)P2CCC (50)
Veliparib
Acute Myeloid Leukemia
National Cancer Institute (NCI)P2CCC (50)
Belinostat
Follicular Lymphoma
National Cancer Institute (NCI)P1CCC (50)
Avelumab
Castration-Resistant Prostate Carcinoma
National Cancer Institute (NCI)P1/2CCC (50)
Berzosertib
Lung Cancer
National Cancer Institute (NCI)P1/2CCC (50)
Bet Bromodomain Inhibitor Zen-3694
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P1/2CCC (50)
Cyclophosphamide
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P1/2CCC (50)
Navitoclax
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P1/2CCC (50)
Telaglenastat
Lung Cancer
National Cancer Institute (NCI)P1/2CCC (50)
Showing 2376 to 2400 of 3,272 assets
PreviousPage 96 of 131Next